Company Information

United States
Founded in
Gene TherapyCell TherapyImmune-OncologyRare Disease
AVROBIO’s vision is to bring personalized gene therapy to the world. We aim to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone. Our ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by our industry leading plato® gene therapy platform, our foundation designed to deliver gene therapy worldwide. We are headquartered in Cambridge, Mass., with an office in Toronto, Ontario. For additional information visit and follow us on Twitter

Sign Up to View AVROBIO’s Top Employees

Instant access. Cancel anytime

Similar Companies

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

Instant access. Cancel anytime

Get Contact Info for All Employees


Danny Bogalhas

Senior Manager of IT Operations

Andreas Kouri

SVP, Global Supply Chain & External Manufacturing

Scott Gottesman

Vice President , Human Resources

Claudia Fiorini

Associate Director, Research and Preclinical Development